Firefly Neuroscience Reports Executive Changes and Agreement Termination
Ticker: AIFF · Form: 8-K · Filed: Sep 5, 2025 · CIK: 803578
Sentiment: neutral
Topics: management-change, agreement-termination, filing
TL;DR
Firefly Neuroscience is shaking things up: execs out, new ones in, and a big deal just got terminated.
AI Summary
Firefly Neuroscience, Inc. announced on August 29, 2025, the termination of a material definitive agreement. The company also reported the departure of directors or certain officers, the election of directors, and the appointment of certain officers, along with compensatory arrangements for these officers. The filing also includes financial statements and exhibits.
Why It Matters
This filing indicates significant internal changes at Firefly Neuroscience, including executive and director shifts and the end of a key contract, which could impact the company's strategic direction and operations.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and changes in leadership introduce uncertainty regarding the company's future strategy and financial stability.
Key Players & Entities
- FIREFLY NEUROSCIENCE, INC. (company) — Registrant
- August 29, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 1100 Military Road (address) — Business address
FAQ
What was the material definitive agreement that was terminated?
The filing does not specify the details of the material definitive agreement that was terminated.
Who are the directors or officers that departed?
The filing states that there was a departure of directors or certain officers but does not name the individuals involved.
Who were the newly elected directors or appointed officers?
The filing mentions the election of directors and appointment of certain officers but does not provide their names.
What are the compensatory arrangements for the newly appointed officers?
The filing indicates that compensatory arrangements for certain officers are included but does not detail these arrangements.
What financial statements and exhibits are included with this filing?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
Filing Stats: 662 words · 3 min read · ~2 pages · Grade level 11.9 · Accepted 2025-09-05 16:03:50
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share AIFF The Nasdaq Capital M
- $10 million — specified in the ELOC Agreement, up to $10 million of the Company's common stock, par valu
- $165,000 — l gross base salary is increased from CA$165,000 (approximately US$120,000) to CA$216,00
- $120,000 — reased from CA$165,000 (approximately US$120,000) to CA$216,000 (approximately US$157,00
- $216,000 — 165,000 (approximately US$120,000) to CA$216,000 (approximately US$157,000) effective Se
- $157,000 — 120,000) to CA$216,000 (approximately US$157,000) effective September 1, 2025. All other
Filing Documents
- ea0256226-8k_firefly.htm (8-K) — 27KB
- ea025622601ex10-1_firefly.htm (EX-10.1) — 7KB
- ex10-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-085006.txt ( ) — 199KB
- aiff-20250829.xsd (EX-101.SCH) — 3KB
- aiff-20250829_lab.xml (EX-101.LAB) — 33KB
- aiff-20250829_pre.xml (EX-101.PRE) — 22KB
- ea0256226-8k_firefly_htm.xml (XML) — 3KB
02 Termination of a Material Definitive Agreement
Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed in the Current Report on Form 8-K filed by the Firefly Neuroscience, Inc. (the "Company") on December 23, 2024, the Company entered into a purchase agreement ("ELOC Agreement") with Arena Business Solutions Global SPC II, Ltd ("Arena"), dated December 20, 2024, pursuant to which Arena had committed to purchase, upon the terms and conditions specified in the ELOC Agreement, up to $10 million of the Company's common stock, par value $0.0001 per share. On September 4, 2025, the Company delivered written notice to Arena to terminate the ELOC Agreement pursuant to its terms, which such termination to be effective as of September 11, 2025.
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 29, 2025, the Board of Directors (the "Board") of the Company approved an amendment (the "Amendment") to the employment agreement (the "Krzywicki Employment Agreement"), dated March 12, 2025, by and between Deel Canada Services Inc. ("Deel"), which provides consulting services to the Company, and Paul Krzywicki, the Chief Financial Officer of the Company. On the same date, Deel and Mr. Krzywicki executed the Amendment. Pursuant to the Amendment, Mr. Krzywicki's annual gross base salary is increased from CA$165,000 (approximately US$120,000) to CA$216,000 (approximately US$157,000) effective September 1, 2025. All other terms and conditions of the Krzywicki Employment Agreement remain unchanged and in full force and effect. The foregoing description of the Amendment is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Amendment to Employment Agreement, dated August 29, 2025, by and between Deel Canada Services Inc. and Paul Krzywicki. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document). 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 5, 2025 FIREFLY NEUROSCIENCE, INC. /s/ Greg Lipschitz Name: Greg Lipschitz Title: Chief Executive Officer 2